Form 8-K UDR, Inc. For: May 19
http://archive.fast-edgar.com/20220523/A8BZ2222Z228N2Z2222K22ZZKV9BZZJ22Q42
Filed on: May 23, 2022
Form POS AMI PIMCO FUNDS
http://archive.fast-edgar.com/20220523/A822L22DZZ2RB9ZZ27JM2ZYRDQSAOZ22Z242
Filed on: May 23, 2022
Form 424B2 UBS AG
The information in this Preliminary Terms Supplement is not complete and may be changed. We may not sell these Securities until the Final Terms Supplement, the Prospectus Supplement, the accompanying Product Supplement and the Prospectus (collectively, the "Offering Documents") are delivered in final form. The Offering Documents are not an offer to sell these Securities, and we are not soliciting offers to buy these Securities in any state where the offer or sale is... (continue reading...)
Form 4 Genpact LTD For: May 19 Filed by: Madden James C.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form SC14D9C Entasis Therapeutics Filed by: Entasis Therapeutics Holdings Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT PURSUANT TO SECTION 14(d)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
Entasis Therapeutics Holdings Inc.
(Name of Subject Company)
Entasis Therapeutics Holdings Inc.
(Name of Person(s) Filing Statement)
... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-A12B Lionheart Acquisition
-
Form SC 13G/A Portillo's Inc. Filed by: Select Equity Group, L.P.
-
Form 10-Q Breeze Holdings Acquisit For: Mar 31
-
Form D Carmel Co
-
Form 4 LEXICON PHARMACEUTICALS, For: May 21 Filed by: Swain Judith L
-
Form 10-K TRIUMPH GROUP INC For: Mar 31
-
Form 10-D COMM 2015-LC19 Mortgage For: May 12
-
Form 4 Genpact LTD For: May 19 Filed by: Lindstrom Carol
-
Form 4 BEYOND MEAT, INC. For: May 20 Filed by: WITTEMAN TERI L
-
Form 4 HAEMONETICS CORP For: May 19 Filed by: Strong Stewart W
-
Form 8-K NEXTERA ENERGY INC For: May 19
-
Form 8-K Armour Residential REIT, For: May 23
-
Form 8-K NEUROCRINE BIOSCIENCES For: May 18
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form D Westrock Kivu Fund, LP
-
Form 4 LEXICON PHARMACEUTICALS, For: May 21 Filed by: SOBECKI CHRISTOPHER J
-
Form 424B2 UBS AG
-
Form 4 WESTERN ASSET INFLATION- For: May 19 Filed by: GATES WILLIAM H III
-
Form 10-Q MEI Pharma, Inc. For: Mar 31
-
Form 10-D COMM 2014-CCRE20 Mortgag For: May 12
-
Form 8-K Symbolic Logic, Inc. For: May 23
-
Form 4 CARRIAGE SERVICES INC For: May 20 Filed by: Quezada Carlos R.
-
Form 4 CVENT HOLDING CORP. For: May 19 Filed by: Martin Marcela
-
Form 425 Biotech Acquisition Co Filed by: Biotech Acquisition Co
-
Form 8-K CBRE GROUP, INC. For: May 18
-
Form 4 BrightView Holdings, For: May 20 Filed by: DONNELLY THOMAS C
-
Form 4 HAEMONETICS CORP For: May 19 Filed by: Simon, Christopher
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
-
Form 4 Genpact LTD For: May 19 Filed by: Franklin Tamara
-
Form 4 TELEPHONE & DATA SYSTEMS For: May 22 Filed by: Hanley Joseph R
-
Form SC 13D SERVOTRONICS INC /DE/ Filed by: Wax Asset Management, LLC
-
Form 8-K Clean Energy Fuels Corp. For: May 19
-
Form 425 OceanTech Acquisitions Filed by: OceanTech Acquisitions I Corp.
-
Form 4 Honest Company, Inc. For: May 20 Filed by: Vlahos Nikolaos A
-
Form 10-Q XCel Brands, Inc. For: Mar 31
-
Form 8-K Entasis Therapeutics For: May 23
-
Form 10-Q AxonPrime Infrastructure For: Mar 31
-
Form 10-Q Clarim Acquisition Corp. For: Mar 31
-
Form 4 LEXICON PHARMACEUTICALS, For: May 21 Filed by: NIES ALAN S
-
Form S-8 UNIVERSAL STAINLESS &
-
Form 8-K Skyline Champion Corp For: May 23
-
Form 8-K Palo Alto Networks Inc For: May 17
-
Form 4 WESTERN ASSET INFLATION- For: May 19 Filed by: GATES WILLIAM H III
-
Form 8-K NUCOR CORP For: May 18
-
Form 4 HAEMONETICS CORP For: May 19 Filed by: Miller Laurie A.
-
Form 4 Exela Technologies, Inc. For: May 17 Filed by: CHADHA PAR
-
Form 6-K Orphazyme A/S For: May 23
-
Form 8-K Monroe Capital Income For: May 17
-
Form 4 LEXICON PHARMACEUTICALS, For: May 21 Filed by: Palantoni Frank
-
Form 10-Q BitNile Holdings, Inc. For: Mar 31